GHRSGH Research PLC

Healthcare
$21.03+58% 1Y

The financials

GH Research PLC by the numbers

GH Research PLC income statement, Q4 2025 against the same quarter a year earlier
Income statementQ4 2025Q4 2024Change
Operating income−$17M−$13Mn/a
Net income−$14M−$8.8Mn/a
Diluted EPS−$0.23−$0.17n/a

Biotechnology

Ranks #116 of 196 by RyuScore

Compare peers
ANAB-0.50%
AnaptysBio, Inc.
BCAX+1.4%
Bicara Therapeutics Inc.
ABSI+14%
Absci Corporation
ZYME+2.2%
Zymeworks Inc.
INVA+1.7%
Innoviva, Inc.
SNDX+0.59%
Syndax Pharmaceuticals, Inc.